Jones Keith Anthony
SEC insider (Form 3/4/5 filer). CIK 0002026411. Director at Humacyte, Inc. (HUMA). 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in DURHAM, NC.
Companies Jones Keith Anthony has filed insider reports for
- Humacyte, Inc. (HUMA): Director
Jones Keith Anthony
CIK: 0002026411
Transaction Breakdown
Open Market Buys (P)3 (60.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HUMA
Humacyte, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 14, 2026HUMA
Humacyte, Inc.
PurchaseDirect10K shares at avg. $0.56$6K - Aug 20, 2026HUMA
Humacyte, Inc.
PurchaseDirect10K shares at avg. $0.69$7K - Aug 17, 2026HUMA
Humacyte, Inc.
PurchaseDirect30K shares at avg. $0.59$18K - Jun 11, 2026HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
80K shares- - Jun 12, 2025HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
80K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 | HUMA Humacyte, Inc. | Purchase | 10,000 | $0.56 | $5,620 | Direct |
| Aug 20, 2026 | HUMA Humacyte, Inc. | Purchase | 10,000 | $0.69 | $6,930 | Direct |
| Aug 17, 2026 | HUMA Humacyte, Inc. | Purchase | 30,000 | $0.59 | $17,820 | Direct |
| Jun 11, 2026 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 80,000 | - | - | Direct |
| Jun 12, 2025 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 80,000 | - | - | Direct |
1-5 of 5 transactions